|
| 36824860 | Early Treatment, Inflammation and Post-COVID Conditions. | medRxiv | 2023 |
| 37659419 | Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. | Lancet Microbe | 2023 |
| 37534607 | Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. | Transfusion | 2023 |
| 37403547 | Current advances in 2022: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee. | Transfusion | 2023 |
| 36971017 | Transfusion of ABO-group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients. | Transfusion | 2023 |
| 37131659 | Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. | medRxiv | 2023 |
| 36815517 | Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study. | Transfusion | 2023 |
| 36722044 | Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial. | J Infect Dis | 2023 |
| 34889809 | Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma. | Blood Coagul Fibrinolysis | 2022 |
| 35352362 | How do I implement an outpatient program for the administration of convalescent plasma for COVID-19? | Transfusion | 2022 |
| 35797471 | Race, rituximab, and relapse in TTP. | Blood | 2022 |
| 35834523 | Vitamin K antagonist reversal strategies: Systematic review and network meta-analysis from the AABB. | Transfusion | 2022 |
| 35780813 | Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial. | Chest | 2022 |
| 35748692 | Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study. | Transfusion | 2022 |
| 35713186 | Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee. | Transfusion | 2022 |
| 35353960 | Early Outpatient Treatment for Covid-19 with Convalescent Plasma. | N Engl J Med | 2022 |
| 35969859 | Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma. | Ann Intern Med | 2022 |
| 34953317 | Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? | Thromb Res | 2022 |
| 33063869 | Use of therapeutic plasma exchange for pediatric neurological diseases. | J Clin Apher | 2021 |
| 33743799 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Trials | 2021 |
| 33626571 | Models for plasma kinetics during simultaneous therapeutic plasma exchange and extracorporeal membrane oxygenation. | Math Med Biol | 2021 |
| 33586160 | COVID-19 convalescent plasma: Interim recommendations from the AABB. | Transfusion | 2021 |
| 33688640 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Res Sq | 2021 |
| 34981068 | Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. | medRxiv | 2021 |
| 34423446 | Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee. | Transfusion | 2021 |
| 34531809 | Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence. | Front Neurol | 2021 |
| 34269429 | Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury. | Transfusion | 2021 |
| 33955863 | A little heparin goes a long way: effect of therapeutic levels of unfractionated heparin on the heparin-induced thrombocytopenia-platelet factor 4 ELISA antibody assay. | Blood Coagul Fibrinolysis | 2021 |
| 33030779 | Mathematical modeling of the impact of recirculation on exchange kinetics in tandem extracorporeal membrane oxygenation and therapeutic plasma exchange. | J Clin Apher | 2021 |
| 32449953 | Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass? | J Clin Apher | 2020 |
| 31783402 | The Impact of an Undergraduate Biology Class on Donor Recruitment at a Hospital-Based Blood Donor Center. | Am J Clin Pathol | 2020 |
| 31696530 | Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis. | J Clin Apher | 2020 |
| 31774189 | Total plasma volume determinations for patients with potentially challenging conditions requiring therapeutic plasma exchange: Dealer's choice. | J Clin Apher | 2020 |
| 31705563 | Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee. | J Clin Apher | 2020 |
| 33063875 | Adverse event reporting for cellular therapy products: Current status and future directions. | Transfusion | 2020 |
| 32603068 | Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications. | Am Fam Physician | 2020 |
| 32767584 | A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID-19. | J Clin Apher | 2020 |
| 32901965 | Transfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patients. | Transfusion | 2020 |
| 32643156 | How do I manage long-term blood component shortages in a hospital transfusion service? | Transfusion | 2020 |
| 32696551 | Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients. | Transfusion | 2020 |
| 32812222 | Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review. | Transfusion | 2020 |
| 32779705 | Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019. | J Infect Dis | 2020 |
| 32472580 | Current advances in transfusion medicine: a 2019 review of selected topics from the AABB Clinical Transfusion Medicine Committee. | Transfusion | 2020 |
| 32441353 | Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity. | Transfusion | 2020 |
| 32374920 | Viscoelastic testing in COVID-19: a possible screening tool for severe disease? | Transfusion | 2020 |
| 32478907 | Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness. | Transfusion | 2020 |
| 30548267 | Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods. | Transfusion | 2019 |
| 31645275 | Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies. | Transfus Med Rev | 2019 |
| 31471735 | Transfusion as a Palliative Strategy. | Curr Oncol Rep | 2019 |
| 31309091 | The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical students. | Blood Res | 2019 |